< 生产厂家价格 >

异香兰酸甲酯

异香兰酸甲酯用途

异钒酸甲酯是从牡荆中分离出来的次级代谢产物[1]。

点击显示

异香兰酸甲酯名称

[ CAS 号 ]:
6702-50-7

[ 中文名 ]:
3-羟基-4-甲氧基苯甲酸甲酯

[ 英文名 ]:
Methyl isovanillate

[中文别名 ]:

[英文别名 ]:

Methyl 3-hydroxy-4-methoxybenzenecarboxylate
Isovanillic Acid Methyl Ester
MFCD01321262
1OVR CQ DO1
Methyl isovanillate
3-hydroxy-4-methoxy-benzoic acid methyl ester
3-Hydroxy-4-methoxybenzoic acid methyl ester
Methyl 3-hydroxy-4-methoxybenzoate
methyl 3-hydroxy-4-methoxy-benzoate
Benzoic acid, 3-hydroxy-4-methoxy-, methyl ester

异香兰酸甲酯生物活性

[ 描述 ]:

异钒酸甲酯是从牡荆中分离出来的次级代谢产物[1]。

[ 相关类别 ]:

研究领域 >> 其他

信号通路 >> 其他 >> 其他

[参考文献]

[1]. Alper GÖKBULUT, et al. Radical Scavenging Activity and Vitexin Content of Vitex agnus-castus Leaves and Fruits. FABAD J. Pharm. Sci. 35, 85-91, 2010

异香兰酸甲酯物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
327.7±22.0 °C at 760 mmHg

[ 熔点 ]:
64-67ºC

[ 分子式 ]:
C₉H₁₀O₄

[ 分子量 ]:
182.173

[ 闪点 ]:
132.8±15.8 °C

[ 精确质量 ]:
182.057907

[ PSA ]:
55.76000

[ LogP ]:
1.75

[ 外观性状 ]:
固体

[ 蒸汽压 ]:
0.0±0.7 mmHg at 25°C

[ 折射率 ]:
1.534

[ 储存条件 ]:
室温，密封

异香兰酸甲酯MSDS

异香兰酸甲酯安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi:Irritant;

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36

[ 危险品运输编码 ]:
NONH for all modes of transport

[ 海关编码 ]:
2918990090

异香兰酸甲酯合成路线

异香兰酸甲酯上下游产品

异香兰酸甲酯上游产品

异香兰酸甲酯下游产品

异香兰酸甲酯海关

[ 海关编码 ]: 2918990090

[ 中文概述 ]:
2918990090. 其他含其他附加含氧基羧酸（包括酸酐、酰卤化物、过氧化物和过氧酸及该税号的衍生物）. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

异香兰酸甲酯文献

Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk).

Bioorg. Med. Chem. Lett. 21 , 3152-3158, (2011)

Continued examination of substituted 6-arylquinazolin-4-amines as Clk4 inhibitors resulted in selective inhibitors of Clk1, Clk4, Dyrk1A and Dyrk1B. Several of the most potent inhibitors were validate...

更多文献